진단용 MRI 장비 시장 예측(2026-2032년)

The Diagnostic MRI Equipment Market is projected to grow by USD 11.98 billion at a CAGR of 7.57% by 2032.

Diagnostic MRI Equipment: Executive Overview

Diagnostic MRI equipment supports noninvasive imaging across neurological, musculoskeletal, cardiovascular, oncological, and other clinical applications. Demand is shaped by the need for earlier diagnosis, improved image quality, efficient clinical workflows, and broader access to advanced imaging services. The market encompasses systems, coils, accessories, software, and related service capabilities used by hospitals, outpatient centers, and specialized imaging providers.

Workflow, Access, and Clinical Performance Are Reshaping MRI

The landscape is shifting toward higher productivity, more patient-centered examinations, and greater integration with digital clinical environments. Developments in faster acquisition, motion management, abbreviated protocols, image reconstruction, and remote service support can help address throughput constraints and examination complexity. At the same time, providers are balancing clinical ambition with installation requirements, infrastructure limitations, staffing needs, maintenance obligations, and the total cost of ownership.

Artificial Intelligence Is Increasing the Value of MRI Data

Artificial intelligence is being applied to image reconstruction, denoising, protocol selection, segmentation, lesion detection, quality assurance, and workflow prioritization. These tools can support shorter examinations, more consistent image quality, and improved radiologist productivity, but their value depends on representative validation data, interoperability, explainability, cybersecurity, and effective human oversight. Successful adoption therefore requires governance that connects algorithm performance with clinical safety and operational outcomes.

Regional Insights: Uneven Access and Different Adoption Priorities

North America generally emphasizes advanced imaging capability, outpatient workflow efficiency, reimbursement alignment, and data-enabled clinical operations. Europe combines established installed bases with strong attention to quality, privacy, sustainability, and cross-border regulatory requirements. Asia-Pacific includes rapidly expanding diagnostic capacity alongside substantial variation between urban and rural settings. Latin America is influenced by affordability, import dependence, service availability, and concentration of advanced care in major cities. The Middle East is developing specialized healthcare infrastructure while prioritizing high-end clinical services and local capacity building. Africa presents significant unmet access needs, with adoption often constrained by capital availability, reliable power, maintenance coverage, and shortages of trained personnel.

Group Insights: Policy, Trade, and Health-System Structure Matter

ASEAN markets reflect varied levels of healthcare infrastructure, procurement capacity, and urban concentration, making adaptable systems and service support important. BRICS members combine large patient populations with diverse public and private delivery models and differing domestic manufacturing capabilities. The European Union places substantial weight on regulatory conformity, data governance, interoperability, and coordinated health-system priorities. G7 countries tend to emphasize clinical evidence, safety, productivity, and technology integration within mature healthcare systems. GCC markets commonly prioritize advanced facilities, specialized care, and national healthcare transformation programs. NATO members span different procurement and health-system environments, but resilience, secure infrastructure, and continuity of critical medical services remain relevant considerations.

Country Insights: Distinct Infrastructure and Adoption Conditions

Australia and Canada must address geographic dispersion and the cost of serving remote communities. Brazil, Mexico, India, China, and Russia combine substantial diagnostic needs with pronounced differences in regional infrastructure and healthcare access. France, Germany, Italy, Spain, and the United Kingdom operate within mature European clinical and regulatory environments while managing capacity, workforce, and budget pressures. Japan and South Korea show strong technology capabilities and aging-population needs, with emphasis on workflow efficiency and clinical precision. The United States has broad advanced-imaging utilization and diverse provider economics, with continued attention to access, productivity, interoperability, and safety.

Priorities for Leaders: Build Capability Around Outcomes, Not Hardware Alone

Industry leaders should segment solutions by clinical use case, site capability, patient population, and workflow maturity rather than relying on a single equipment proposition. They should demonstrate value through validated measures such as examination time, repeat-scan reduction, diagnostic confidence, uptime, staff productivity, and patient experience. Investment decisions should include installation, power, cooling, service, cybersecurity, training, and lifecycle requirements. Leaders should also establish responsible AI controls, strengthen interoperability, develop regional service networks, support workforce training, and design financing or partnership models that can improve access without compromising quality.

Research Methodology: Evidence-Based Market Assessment

This executive summary uses the defined diagnostic MRI equipment scope and organizes findings across technology, workflow, clinical application, geography, and healthcare-system conditions. Insights should be validated through triangulation of peer-reviewed research, regulatory publications, health-system documents, procurement records, clinical guidance, technology assessments, and interviews with qualified industry and care-delivery stakeholders. Qualitative interpretation should distinguish documented evidence from informed inference and should account for differences in reimbursement, infrastructure, installed equipment, workforce, and regulatory requirements across regions and countries. No market estimates, market shares, forecasts, or company-specific claims are included.

Conclusion: MRI Progress Depends on Integrated Clinical and Operational Design

Diagnostic MRI equipment is evolving from standalone imaging hardware into an integrated platform for clinical decision-making, workflow management, and data-supported care. The strongest opportunities will favor solutions that combine reliable image quality, efficient examinations, responsible artificial intelligence, service resilience, and fit with local infrastructure. Leaders that align technology development with measurable clinical outcomes, workforce realities, regulatory obligations, and equitable access will be better positioned to create durable value across diverse healthcare environments.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Diagnostic MRI Equipment Market, by Product Type

• 7.1. Introduction
• 7.2. Closed Bore Systems
  • 7.2.1. Standard Closed Bore
  • 7.2.2. Wide Closed Bore
• 7.3. Open Systems
  • 7.3.1. Open Bore
  • 7.3.2. True Open
• 7.4. Dedicated Extremity Systems
• 7.5. Upright And Positional Systems

8. Diagnostic MRI Equipment Market, by Magnet Type

• 8.1. Introduction
• 8.2. Permanent
• 8.3. Superconducting

9. Diagnostic MRI Equipment Market, by Field Strength

• 9.1. Introduction
• 9.2. 1.5T
• 9.3. 3T
• 9.4. Above 3T
• 9.5. Below 1.5T

10. Diagnostic MRI Equipment Market, by Service

• 10.1. Introduction
• 10.2. Installation And Maintenance
• 10.3. Support And Maintenance
• 10.4. Training And Consulting
• 10.5. Upgrades

11. Diagnostic MRI Equipment Market, by Application

• 11.1. Introduction
• 11.2. Cardiovascular
  • 11.2.1. Cardiac
  • 11.2.2. Vascular
• 11.3. Musculoskeletal
  • 11.3.1. Orthopedic
  • 11.3.2. Soft Tissue
• 11.4. Neurology
  • 11.4.1. Brain
  • 11.4.2. Peripheral Nerve
  • 11.4.3. Spinal Cord
• 11.5. Oncology
  • 11.5.1. Cancer Staging
  • 11.5.2. Tumor Detection

12. Diagnostic MRI Equipment Market, by End User

• 12.1. Introduction
• 12.2. Ambulatory Care Centers
• 12.3. Diagnostic Imaging Centers
• 12.4. Hospitals
• 12.5. Research Centers

13. Diagnostic MRI Equipment Market, by Region

• 13.1. Introduction
• 13.2. Asia-Pacific
• 13.3. North America
• 13.4. Latin America
• 13.5. Europe
• 13.6. Middle East
• 13.7. Africa

14. Diagnostic MRI Equipment Market, by Group

• 14.1. Introduction
• 14.2. ASEAN
• 14.3. GCC
• 14.4. European Union
• 14.5. BRICS
• 14.6. G7
• 14.7. NATO

15. Diagnostic MRI Equipment Market, by Country

• 15.1. Introduction
• 15.2. United States
• 15.3. Canada
• 15.4. Mexico
• 15.5. Brazil
• 15.6. United Kingdom
• 15.7. Germany
• 15.8. France
• 15.9. Russia
• 15.10. Italy
• 15.11. Spain
• 15.12. China
• 15.13. India
• 15.14. Japan
• 15.15. Australia
• 15.16. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. Market Concentration Analysis, 2025
  • 16.2.1. Concentration Ratio (CR)
  • 16.2.2. Herfindahl Hirschman Index (HHI)
• 16.3. Recent Developments & Impact Analysis, 2025
• 16.4. Product Portfolio Analysis, 2025
• 16.5. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Aspect Imaging Ltd.
• 17.2. Bruker
• 17.3. Canon Medical Systems
• 17.4. Carestream Health
• 17.5. Esaote S.p.A.
• 17.6. FONAR Corporation
• 17.7. Fujifilm Holdings Corp.
• 17.8. GE HealthCare
• 17.9. Hitachi Medical Corporation
• 17.10. Hyperfine, Inc.
• 17.11. Koninklijke Philips N.V.
• 17.12. Mindray
• 17.13. Neusoft Medical Systems
• 17.14. Shenzhen Anke High-Tech Co., Ltd.
• 17.15. Siemens Healthineers
• 17.16. Synaptive Medical
• 17.17. Time Medical Holding
• 17.18. United Imaging Healthcare Co., Ltd.

18. Key Experts